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Although loricrin is the predominant protein of the corniﬁed envelope (CE) in keratinocytes, loss or gain of loricrin
function in mouse models produces only modest skin phenotypes. In contrast, insertional mutations resulting in a
frameshift in the C-terminal domain of loricrin produce the characteristic ichthyosis of loricrin keratoderma in
mouse and man. To ascertain the basis for the loricrin keratoderma phenotype, we assessed epidermal structure
and stratum corneum (SC) function in a previously genotyped human loricrin keratoderma kindred. Our studies
revealed abnormal corneocyte fragility and basal permeability barrier function, but accelerated repair kinetics.
Despite fragility, increased water loss occurred predominantly via extracellular domains, which correlated with
disorganized lamellar bilayers that were linked spatially to discontinuities of the CE. Accelerated barrier recovery
was explicable by ampliﬁed lamellar body secretion, while partial normalization of the CE in the outer SC correlated
with persistence of abundant calcium in the extracellular spaces (positioned to activate transglutaminase-1).
These results show that the barrier abnormality in loricrin keratoderma is linked to a defective CE scaffold,
resulting in increased extracellular permeability, as shown previously for another ‘‘scaffold disorder’’, lamellar
ichthyosis. But in contrast to lamellar ichthyosis, the CE scaffold partially normalizes in the outer SC in loricrin
keratoderma.
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Loricrin is a glycine–serine–cysteine-rich protein, synthesized
in the granular (stratum granulosum, SG) layer (Mehrel et al,
1990; Steven et al, 1990; Hohl et al, 1991). In the outermost
layer of the SG, loricrin migrates to the cell periphery, where
it is deposited beneath the plasma membrane, and cross-
linked to several other cytosolic proteins (e.g., involucrin,
small proline rich proteins (SPRR), elafin, repetin, S100, and
up to  20 other proteins) by transglutaminase-1, forming
the cornified envelope (CE). Comprising up to 80% of CE
proteins, loricrin accounts for much of its mechanical
resistance (Bickenbach et al, 1995; Steinert and Marekov,
1995; Steinert and Marekov, 1999). Yet, the CE not only
protects against external injury, it also serves as a scaffold
for the deposition of the extracellular lamellar bilayers. These
bilayers are linked, in turn, to the CE through an interposed
layer of covalently bound o-hydroxyceramides, the corni-
fied-bound lipid envelope (CLE) (Swartzendruber et al, 1987;
Wertz et al, 1989; Marekov and Steinert, 1998; Nemes et al,
1999; Behne et al, 2000). The extracellular lamellar mem-
branes seal the extracellular spaces against excess, bidirec-
tional movement of water, electrolytes, and xenobiotes (Elias
et al, 2003). Comprised mainly of cholesterol, free fatty acids,
and ceramides, the extracellular lamellae derive from the
secretion of lamellar body (LB) contents at the SG–stratum
corneum (SC) interface, a process that occurs immediately
prior to loricrin cross-linking into the CE (Bickenbach et al,
1995). The combination of a hydrophobic extracellular
compartment, linked to a mechanically resistant protein
scaffold, not only provides an effective interface between the
body and the environment (Downing, 1992; Jackson et al,
1993; Bickenbach et al, 1995; Steinert, 2000), but it also
mediates additional, protective cutaneous functions, such as
antimicrobial, antioxidant, chemical, and mechanical de-
fense (Elias et al, 2003).
Mutations in the human loricrin gene result in a
hyperkeratotic, dominantly inherited skin disorder, loricrin
keratoderma (syn. Vohwinkel syndrome with ichthyosis,
variant of Vohwinkel syndrome, Vohwinkel disease limited
to the skin, OMIM #604117) (Camisa and Rossana, 1984;
Camisa et al, 1988; Maestrini et al, 1996; Armstrong et al,
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1998; Ishida-Yamamoto and Iizuka, 1998; Ishida-Yamamoto
et al, 1998; Takahashi et al, 1999; O’Driscoll et al, 2002).
Clinically, loricrin keratoderma exhibits a characteristic,
honeycomb-like, palmo-plantar keratoderma; generalized
fine-scaling; hyperkeratotic knuckle pads on the dorsal
surface of the fingers; and constricting bands encircling
the fingers and/or toes (pseudoainhum) (Vohwinkel, 1929;
Camisa and Rossana, 1984; Camisa et al, 1988; Maestrini
et al, 1996; Armstrong et al, 1998; Takahashi et al, 1999;
O’Driscoll et al, 2002). Whereas insertional mutations that
result in aberrant, elongated C-terminal domains of one
loricrin allele are found in loricrin keratoderma (Maestrini
et al, 1996), another hyperkeratotic skin disorder, kerato-
derma hereditaria mutilans (syn. classical Vohwinkel dis-
ease, OMIM # 124500) as originally described in 1929 by
Vohwinkel is caused by mutations in connexin 26, and is
associated with deafness in addition to palmo-plantar
keratoderma, but without generalized scaling (Korge et al,
1997; Maestrini et al, 1999).
To better understand the link between the loricrin
genotype and the skin pathology in loricrin keratoderma,
several murine models have been developed with either
loss or gain of loricrin function (Koch et al, 2000; Suga et al,
2000). Although overexpression of human loricrin in
transgenic mice does not yield an abnormal skin phenotype
(Yoneda and Steinert, 1993), loricrin deficiency in knockout
mice results in delayed SC development in utero, and
erythematous, shiny, translucent skin at birth, which largely
resolves by the fourth to fifth postnatal day (Koch et al,
2000). Normalization of the skin phenotype is attributable to
increased compensatory expression of members of the
SPRR family and repetin (Koch et al, 2000; Steinert, 2000).
Despite a lack of L-granules, CE structure in these animals
appears largely normal (Jarnik et al, 2002). In contrast, mice
that recapitulate the C-terminal modification, as in human
loricrin keratoderma, display a persistent skin phenotype
that mimics the human disease (i.e., generalized scaling),
which develops within the first 3 d of postnatal life,
constricting bands encircling the tail, and thickening of foot
pads (Suga et al, 2000). In these mice, the mutant loricrin
appears to be retained in the nuclei of the SG and SC
layers, and fails to reach the CE (Suga et al, 2000). The
relationship between the aberrant localization of the mutant
loricrin and the phenotypic features of loricrin keratoderma
remains unclear. Although dominant/negative interference
of the mutant with the wild-type polypeptide has been
proposed (Maestrini et al, 1996), alternatively, insufficient
amounts of intact protein (haploinsufficiency) could account
for the phenotype. Regardless of the precise molecular
mechanism, we hypothesized that abnormal SC structure is
an important pathophysiologic feature of loricrin keratoder-
ma, resulting in an exaggerated hyperplasia, which may be
secondary to a barrier abnormality.
Accordingly, abnormal epidermal permeability barrier
function was reported in mice with the murine mimic of
human loricrin keratoderma (Suga et al, 2000). Barrier
abnormalities have been noted in a number of ichthyoses
associated with structural protein abnormalities. For exam-
ple, transglutaminase-1 mutations result in a barrier
abnormality in lamellar ichthyosis (Ghadially et al, 1992;
Lavrijsen et al, 1993; Elias et al, 2002), and barrier
abnormalities also occur in mice with deletion of this
enzyme (Matsuki et al, 1998; Kuramoto et al, 2002). In
addition, mutations in keratins 1 or 10 in epidermolytic
hyperkeratosis are accompanied by a barrier abnormality
(Schmuth et al, 2001b). Human loricrin keratoderma, should
it also display a permeability barrier abnormality, as does
the murine mimic (Suga et al, 2000), would provide a
valuable model to test the role of the major protein
constituent of the CE in epidermal permeability barrier
function. To dissect the pathogenesis, we assessed first,
the range of functional abnormalities present in a large
kindred of previously genotyped patients with loricrin
keratoderma (Maestrini et al, 1996). Involved skin demon-
strated a marked increase in basal water loss (TEWL), an
accelerated repair response following acute perturbations,
reduced hydration, and cohesion as well as increased skin
fragility in most subjects. Despite evidence of increased
fragility, lanthanum tracer studies showed that the perme-
ability barrier abnormality in loricrin keratoderma is attribu-
table predominantly to increased extracellular, rather than
transcellular, movement of water. An attenuated CE
explains both increased corneocyte fragility, and the
marked disorganization of the extracellular lamellar bilayer
system (scaffold abnormality), leading to increased trans-
cutaneous water loss. Yet, partial normalization of the CE
abnormality in the outer SC probably accounts for the
relatively mild clinical phenotype in loricrin keratoderma
versus another CE scaffold disorder, lamellar ichthyosis.
Results
Loricrin keratoderma subjects display abnormal epider-
mal barrier function, hydration and SC cohesion We had
an opportunity to evaluate not only the originally described
subjects (Maestrini et al, 1996), but also additional members
of the kindred (Tables S1 and S2). We first assessed basal
permeability barrier function over two separate, non-sun-
exposed body sites of subjects and controls, representing
the two principal loricrin keratoderma skin phenotypes; i.e.,
volar wrist skin (honeycomb-like hyperkeratotic changes),
and proximal volar forearm (fine-scaly ichthyosis). Over the
wrist area, basal TEWL rates were markedly increased, with
a mean of 24.9 g per m2 per h in subjects versus 8.8 g per
m2 per h (po0.05) over the same site in unrelated control
subjects (Fig 1A). Basal TEWL rates also were increased
over the volar forearm area, with a mean of 12.1 g per m2
per h in patients versus 6.9 g per m2 per h (po0.05) in
unrelated, normal control subjects over the same location
(Fig 1A). Loricrin keratoderma subjects also displayed other
functional abnormalities, including markedly reduced SC
hydration in the hyperkeratotic/honeycomb-type skin sites.
Furthermore, the surface pH of the SC showed a trend
towards being more acidic in loricrin keratoderma than in
control subjects, but the difference did not achieve
statistical significance (Fig 1C).
We next compared the SC response to acute abrogation
mechanical stress in affected versus control subjects. When
the permeability barrier was experimentally perturbed by
tape stripping to a maximal 4TEWL 2-fold higher than
basal levels, SC cohesion was markedly reduced in loricrin
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keratoderma as determined by measurement of the amount
of protein removed per tape strip (Fig 1D). Surprisingly,
severely affected loricrin keratoderma demonstrated super
normal recovery response after tape stripping if compared
to control subjects at 3 and/or 6 h (Fig 2). These results
show that loricrin keratoderma subjects, despite a promi-
nent basal barrier abnormality and decreased SC cohesion,
exhibit accelerated barrier recovery kinetics after acute
barrier disruption.
Basis for skin fragility in loricrin keratoderma On
histology, biopsies from loricrin keratoderma revealed the
previously described characteristics, including epidermal
hyperplasia, hypergranulosis, marked hyperkeratosis, and
parakeratosis with characteristic roundish nuclei in the
lower SC as described previously (Maestrini et al, 1996;
Korge et al, 1997). In contrast, biopsies from unaffected
family members displayed a normal epidermis, with an
orthokeratotic SC, indistinguishable from normal skin (not-
shown). In most loricrin keratoderma samples, we observed
an additional, previously unrecognized feature; i.e. a plane
of decreased tissue integrity within or just above the
outermost granular (SG) layer (Fig 3, arrows), with an
enhanced propensity for tissue samples to sheer either with
sectioning or with physical manipulation. On electron
microscopy, the cleavage plane could be further shown to
pass both through and between cells in the outer SG layer
and at the SG–SC interface (Fig 3). Together, these results
demonstrate a zone of decreased tissue integrity in the
outer nucleated layers of the epidermis in loricrin kerato-
derma.
To determine whether this morphologic evidence of
compromised integrity correlated with increased skin
fragility, we used the pencil eraser test, applying controlled
torque and downward pressure to loricrin keratoderma
versus control sites (Williams and Elias, 1981a, b). We
observed an increased tendency for the SC to shear off
(subcorneal disadherence) in a majority of tested loricrin
keratoderma subjects (‘‘pseudo-Nikolskij’’ sign) (Grando
et al, 2003), (Table S1) a clinical feature that has not been
tested previously in loricrin keratoderma, whereas five
similarly treated, control subjects exhibited no such
tendency. Yet, it should be noted that loricrin keratoderma
subjects did not report an increased tendency for symp-
toms attributable to excess skin fragility.
Figure 1
Loricrin keratoderma skin displays functional abnormalities. (A) Transepidermal water loss (TEWL) was measured using a Tewameter (TM210;
Courage & Khazaka, Cologene, Germany) over (i) the wrist area (honeycomb-like changes) (n¼11); (ii) lower forearm (fine-scaling ichthyosis)
(n¼ 11), and the corresponding skin areas of normal control subjects (n¼6). (B) Skin hydration was assessed as stratum corneum (SC) capacitance,
measured with a corneometer (TM825; Courage & Khazaka). (C) Skin surface pH was measured with a Skin-pH-Meter (PH900; Courage & Khazaka).
(D) SC cohesion was assessed as quotient of protein per D-Squame stripping. Data shown represent mean  SEM.
Figure2
Accelerated barrier recovery kinetics accelerate in loricrin kerato-
derma. Barrier recovery was assessed as % change in transepidermal
water loss 3 and 6 h after acute barrier disruption of lorcrin keratoderma
severely affected (distal, n¼8) versus mildly affected (proximal, n¼2)
skin sites by tape stripping, and normal control skin sites.
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To ascertain whether increased fragility results from
alterations in the outer SG layers or impaired resiliance of
the SC to chemical disruption, we next assessed CE
structures after boiling of loricrin keratoderma versus
control scale samples in SDS/DTT, as previously employed
to assess corneoycyte competence in lamellar ichthyosis
(Jeon et al, 1998; Elias et al, 2002). Although lamellar
ichthyosis scale is readily disrupted by this treatment (vida
supra), loricrin keratoderma scale (outer SC) remains intact
after boiling in SDS and DTT, comparable to control scale
(not shown). These results further show that, despite
evidence of enhanced fragility in the SG, the outer SC in
loricrin keratoderma becomes competent.
Abnormal barrier function in loricrin keratoderma is
attributable to increased cellular permeability Utilizing
colloidal lanthanum as a tracer to localize sites of enhanced
water movement, we next assessed whether the basal
barrier abnormality in loricrin keratoderma could be attrib-
uted to enhanced inter- versus trans-cellular movement of
water; i.e., due to porous extracellular domains versus
defective corneocytes. Prior studies have shown that
lanthanum is excluded from normal SC (Wolff and Schteiner,
1968; Elias et al, 1977, 1981, 1984, 2002; Williams and Elias,
1981a, b; Schmuth et al, 2001b), which was again shown
here in unaffected subjects and normals (not shown). In
contrast, lanthanum tracer penetrated bidirectionally deep
into the SC in biopsies from loricrin keratoderma (Figs 4A–
C). Although most of the electron-dense tracer appeared
within the extracellular spaces, small amounts of tracer
leaked into the peripheral cytosol of some corneocytes (Fig
4B), consistent with some water movement into abnormally
fragile corneocytes. Despite evidence of decreased epider-
mal integrity, however, water movement across SC in
loricrin keratoderma occurs primarily via the extracellular
pathway.
Abnormal CE structure accounts for the extracellular
barrier abnormality To assess further the basis for
increased extracellular permeability of the SC in loricrin
keratoderma, we next determined whether the CE scaffold
is abnormal, as in lamellar ichthyosis (Elias et al, 2002). CE
structures in the lower SC appeared markedly attenuated in
loricrin keratoderma versus control biopsy samples, as
reported previously (Korge et al, 1997), and displayed
frequent discontinuities (Figs 5B and C vs 5A and 6B–D vs
6A). To assess whether the attenuated CE in the lower SC of
loricrin keratoderma reflect decreased loricrin deposition,
we next assessed loricrin distribution by immunohisto-
chemistry. As reported previously (Maestrini et al, 1996;
Korge et al, 1997), loricrin deposition was decreased in CE
from loricrin keratoderma versus control subjects as
assessed with an antibody raised against the C-terminus
(not shown). Quantitative studies, performed by a blinded
observer on coded micrographs (see Materials and Meth-
ods), confirmed a reduced thickness of CE in the lower SC
of loricrin keratoderma versus CE in both unaffected relative
and reported values for normal CE (White et al, 1996) (Fig 7),
in contrast to the normal thickness in loricrin knockout mice
when measured on freeze-isolated dried CE (Jarnik et al,
2002). However, in our human loricrin keratoderma skin
samples CE thickness partially normalized (to about 2/3
normal thickness) in the outer SC (5.76  1.01 vs
8.81  0.24 nm; po0.05). In the insert of Fig 6B note CE
of near-normal thickness in outer SC versus lower SC (cf.
Figs 5C and 6B–D). Together, these results demonstrate
Figure 3
Skin fragility localizes to outer
granular layer. Cleavage plane in
mechanically induced fracture of
patient sample passes both between
and across cells of the outer granular
layer (stratum granulosum, SG). (A)
Dark-field view of thick section; (B)
hematoxylin & eosin; (C) toluidine
blue stained semi-thin preparation;
(D) OsO4 post-fixed ultrathin section
at level of outer SG. Scale bars:
A¼ 100 mm; B, C¼ 10 mm; D¼0.5 mm.
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first, a marked CE scaffold abnormality in the lower SC in
loricrin keratoderma; and second, they further support the
hypothesis that peptide precursors, other than loricrin,
continue to be cross-linked into CE during apical migration
from the lower to the upper SC.
Despite evidence of attenuated CE in the lower SC, CLE
ultrastructure appeared normal at all levels of SC in loricrin
keratoderma (Figs 5A, 6C–D; 5B and 6A¼normal). These
morphological studies were further confirmed by biochem-
ical studies, which showed that neither the total bound
o-OH-ceramide content nor its subfractions, o-OH-cera-
mide A or o-OH-ceramide B, differed in loricrin keratoderma
versus normal (sunburn) scale (Table I). There was a
statistically significant decrease, however, in free o-OH
fatty acids in SC from loricrin keratoderma, consistent with
impaired lipid processing of o-OH Cer into o-OH FA by
ceramidase. Together, these results demonstrate an altered
CE, but largely normal CLE structure and composition in
loricrin keratoderma.
Extracellular lamellae are abnormal in loricrin kerato-
derma Two unrelated structural abnormalities could ac-
count for increased extracellular permeability in loricrin
keratoderma: (1) the abnormal CE scaffold could lead to
altered lamellar bilayer organization; or (2) the mutant
loricrin could interfere with LB secretion, leading to a
paucity of secreted LB contents. In examining the first
possibility, extracellular lamellar bilayer organization, as
assessed in RuO4 post-fixed tissue, was abnormal in all
loricrin keratoderma samples (Fig 6B and C). Relatively
normal-appearing membrane arrays alternated with foci
characterized by irregularly configured, loosely organized,
or fragmented lamellar bilayers (Fig 6B and C, asterisks).
Furthermore, consistent with biochemical evidence of
Figure 4
Increased permeability occurs pri-
marily via extracellular pathway.
(A–C) Despite evidence of keratinocyte
fragility, water-soluble, electron-dense
tracer (colloidal lanthanum) enters the
stratum corneum (SC) via extracellular
domains (arrows). Some corneocytes
in lower SC demonstrate (curved
arrows) evidence of fragility, shown
by leakage of tracer into cytosol (B,
open arrows). (A, B) OsO4 post-fixation.
Scale bars: AþB¼ 1 mm; C¼0.5 mm.
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delayed lipid processing (Table I), stacks of incompletely
processed membranes persisted well above the SG–SC
interface (Fig 6D, solid arrows). Biopsies from proximal sites
with milder disease exhibited the same features as did
biopsies from acral sites, but in less exaggerated form
(Fig 6C vs B). Together, these results show that abnormalities
in extracellular membrane structure correlate with the basal
permeability barrier abnormality in loricrin keratoderma.
LB secretion is largely normal in loricrin keratoder-
ma We next explored whether increased extracellular water
movement in loricrin keratoderma could also be attributa-
ble, in part, to cytoskeletal alterations that interfere with
LB secretion, as occurs in epidermolytic hyperkeratosis
(Schmuth et al, 2001). In all patient biopsies we observed:
(a) normal quantities of secreted extracellular lamellae;
consistent with unimpeded secretion (Fig 6A–C); (b) a
normal density of LB, with replete internal contents, in the
upper spinous and SG layers (not shown); (c) largely normal
amounts of secreted LB contents at the SG–SC interface
(Fig 6, asterisks); and (d) relatively little, entombed LB-
derived, lamellar material in the corneocyte cytosol (Fig 6B–
D, double arrows). Whereas these results suggest that LB
assembly and secretion are unimpaired in loricrin kerato-
derma, we further determined LB secretion competence by
assessing the distribution of an enzyme cytochemical
marker of LB contents; i.e., acid lipase (Menon et al,
1986). LB-derived hydrolase contents were regularly deliv-
ered into the SG–SC interface, with little residual, detectable
activity within the corneocyte cytosol in loricrin keratoderma
(Fig 8). Together, these results show that LB secretion
is largely unimpaired, and therefore, that a cytoskeletal
abnormality does not explain the barrier defect in loricrin
keratoderma.
Accelerated LB secretion with normalized lipid proces-
sing account for rapid recovery kinetics We next
assessed the structural basis for the accelerated barrier
recovery response in loricrin keratoderma. Biopsies from
affected versus unaffected family members and normal
Figure 5
Cornified envelopes (CEs) in lower
stratum corneum (SC) are attenu-
ated in loricrin keratoderma. (A, C)
Note thin, CE (solid arrows), with
frequent discontinuities (C, open ar-
rows) in lower SC in loricrin kerato-
derma biopsies versus CE with normal
dimensions in control SC (B, solid
arrows). (A) Open arrow shows normal
CLE in loricrin keratoderma. Delayed
lipid processing is also evident in
lower SC of loricrin keratoderma biop-
sies (A, C, asterisks). (A, B) RuO4 post-
fixation; (C) OsO4 post-fixation. Scale
bar¼ 0.25mm.
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human skin were obtained both 3 and 6 h after tape
stripping, when loricrin keratoderma recovery kinetics
markedly accelerate (cf. Fig 2). As reported previously
(Menon et al, 1992a), in control samples, LB formation and
secretion increased over basal rates after tape stripping,
but secretion remained restricted to the SG–SC interface
(not shown). In contrast, in patient samples secretion began
in the lower SG, and continued at all levels of the granular
layer (Fig 9B and D). As a result, there were increased
quantities of secreted lamellar bilayers in some foci (Fig 9A).
Moreover, lipid processing largely normalized (i.e., there
was little or no unprocessed, secreted LB contents above
the SG–SC interface (Fig 9D; cf. Fig 6D). These results show
that accelerated barrier recovery in loricrin keratoderma is
paralleled by an amplified LB secretory response.
Figure 6
Normal quantities, but abnormal
organization of extracellular lamel-
lae in loricrin keratoderma. (A) Nor-
mal stratum corneum (SC), with typical
extracellular lamellar bilayers (arrows).
(B, C) Attenuated cornified envelope
(CE) are again evident throughout the
lower SC. Although extensive extra-
cellular arrays are present in lori-
crin keratoderma, these bilayers are
loosely organized and often fragmen-
ted (asterisks) in comparison to normal
SC (A, arrows). Findings are com-
parable, but more exaggerated in
severely (B) than in less severely
involved (C) skin sites. (B, inset) Note
CE of near-normal thickness in outer
SC of loricrin keratoderma. Delayed
lipid processing (D, solid arrows) can
be seen again, and some entombed
lamellar bodies are evident (B–D,
double arrows). In contrast, cornified-
bound lipid envelope are normal re-
gardless of disease severity (C, D,
open arrows). (A–D) RuO4 post-fixation.
Scale bar¼ 0.25mm.
Figure7
Cornified envelopes are attenuated in lower layers of loricrin
keratoderma stratum corneum (SC). Cornified envelope thickness
was determined at 0.5 cm intervals in the lower SC of at least 30
randomly obtained micrographs from each biopsy. Values shown
represent mean  SEM.
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Persistence of membrane-associated calcium correlates
with normalization of CE in outer SC Prior studies have
shown that changes in the calcium (Ca2þ ) gradient in vivo
regulate LB secretion (Lee et al, 1992), and that modulations
in extracellular Ca2þ in vivo also regulate keratinocyte
differentiation (Elias et al, 2000b). To determine whether the
accelerated LB secretion in loricrin keratoderma after acute
disruption reflects modulations in the epidermal Ca2þ
gradient, we employed ion capture cytochemistry, as
described previously (Menon et al, 1985). In basal samples,
we observed normal levels of extra- and intracellular Ca2þ
in the outer SG cells in loricrin keratoderma, but in contrast
to healthy control SC, substantial Ca2þ persisted into the
SC in loricrin keratoderma SC, a minimal occurrence in
normal human skin (Fig 10A vs B). In the lower layers of
loricrin keratoderma SC, Ca2þ frequently appeared within
the corneocyte cytosol (Fig 10A), a finding that correlated
with the occasional leakage of lanthanum into corneocytes
(cf. Fig 4). But in the outer layers of loricrin keratoderma SC,
Ca2þ localizes primarily to membrane domains (Fig 10A,
arrows). These results show first that the increased LB
secretory response after acute barrier disruption is not
attributable to qualitative alterations in the epidermal Ca2þ
gradient. Second, the persistence of substantial Ca2þ into
the SC, with further localization to membrane domains,
correlates with partial normalization of CE morphology in
the outer SC of loricrin keratoderma, presumably catalyzing
ongoing transglutaminase-1 activity.
Discussion
The cutaneous permeability barrier resides in the SC, which
consists of extracellular lipid bilayers (mortar), mediating the
permeability barrier against excess water and electrolyte
loss, and a protein component, the corneocyte (bricks),
which provides mechanical resistance to the SC, and
simultaneously, a scaffold for the supramolecular organiza-
tion of the extracellular lamellar bilayers (Jackson et al,
1993). Disorders of cornification can be due to a defect in
either of the two components. Our laboratories have
previously assessed the basis for the permeability barrier
abnormality and the ichthyosiform skin phenotype in a
variety of disorders of cornification (Williams, 1991). The
barrier abnormalities in disorders, such as recessive
x-linked ichthyosis, essential fatty acid deficiency, Refsum’s
disease, and Sjo¨gren–Larssen syndrome, results from
changes in extracellular membrane architecture due to
discrete lipid biochemical defects (Williams and Elias,
1981b, 1985). More recently we have begun to assess the
Table I. Lipid biochemical analysis of covalently bound ceramides in loricrin keratoderma scale
Bound lipids Loricrin keratoderma (lg per mg scale) (mean  SD) Normal (lg per mg scale) (mean  SD)
Total o-OH Cer 1.572  0.373 1.639  0.512
o-OH Cer A 1.144  0.281 1.038  0.322
o-OH Cer B 0.428  0.100 0.601  0.190
o-OH FA 0.230  0.103a 0.657  0.204
Scale samples were assessed from ten loricrin keratoderma and three normal subjects (normal sunburn scale data from Elias et al (2002). Standards
used for quantitative TLC were C24:0 (lignoceric acid), and a-hydroxyacylsphingosine (Sigma, St. Louis, MO). o-OH Cer A contains a sphingosine base,
whereas o-OH Cer B contains a hydroxysphinganine base (Jarnik et al, 2002).
aSignificantly reduced versus normal: po0.05.
Figure 8
Lamellar body secretion is largely
unimpaired in loricrin keratoderma.
(A, B) Acid lipase is used as a
surrogate cytochemical maker for la-
mellar body hydrolase content and
secretion. In granular layer (stratum
granulosum, SG) enzyme activity loca-
lizes to lamellar body contents (A, solid
arrow). In stratum corneum (SC) most
enzyme activity localizes to extracellu-
lar domains (A, B, open arrows). OsO4
post-fixation. Scale bar¼ 0.35mm.
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basis for permeability barrier abnormalities in ichthyoses
associated with structural protein abnormalities. There is
evidence that although corneocyte structural proteins are
known to provide mechanical resilience to the SC, defects
in certain corneocyte structural proteins also can lead to
permeability barrier abnormalities (Ghadially et al, 1992;
Matsuki et al, 1998; Elias et al, 2000a,b, 2002; Koch et al,
2000; Suga et al, 2000; Schmuth et al, 2001b; Kuramoto
et al, 2002). The studies further demonstrate that defi-
ciencies in corneocyte proteins alter permeability barrier
function by a variety of mechanisms. For example,
transglutaminase-1 mutations produce defects in the CE/
CLE scaffold that account for the minor barrier abnormality
both in lamellar ichthyosis (Ghadially et al, 1992; Lavrijsen
et al, 1993; Elias et al, 2002), and in mice with deletion of
this enzyme (Matsuki et al, 1998; Kuramoto et al, 2002). A
defective scaffold also presumably accounts for the minor
barrier abnormality in involucrin knockout mice1, that
otherwise display a grossly normal phenotype (Djian
et al, 2000). In contrast, mutations in keratin 1 or 10 in
epidermolytic hyperkeratosis provoke a barrier abnormality
by interfering with LB exocytosis (cytoskeletal, rather than
scaffold abnormality) (Schmuth et al, 2001b). A third,
unrelated mechanism whereby corneocyte abnormalities
can provoke a permeability barrier abnormality is exempli-
fied by retinoid treatment, which results in attenuated
corneocytes that allow increased transcellular water move-
ments (Williams and Elias, 1981a).
In this study, we assessed the consequences of
mutations in the major CE constituent, loricrin, on epidermal
Figure 9
Accelerated lamellar body (LB) pro-
duction, with premature LB secre-
tion, accounts for normalization of
barrier recovery in loricrin kerato-
derma. (A–D) Three and six hours after
tape stripping (TS-3,6), note abundant
secreted LB contents deep in granular
layer (B, D, arrowheads). Extracellular
bilayer quantities are increased in
many foci (A, arrows), and there is no
evidence of a delay in lipid processing
(C, arrows). (A, C) RuO4 post-fixation;
(B, D) OsO4 post-fixation. Scale bars:
A–C¼0.25 mm; D¼0.5 mm.
1Jensen JM, Dijian P, Proksche E: Disturbed permeability barrier
function in transgenic involucrin deficient mice. J Invest Dermatol,
112:542, 1999 (abstr.).
PATHOPHYSIOLOGY OF LORICRIN KERATODERMA 917122 : 4 APRIL 2004
function and epidermal morphology by studying skin from
patients, which have previously been genotyped for muta-
tions in the loricrin gene (Maestrini et al, 1996). We identified
functional abnormalities in SC hydration, cohesion, and a
marked permeability barrier abnormality. Hence, our studies
aimed at delineating the pathophysiologic link between the
loricrin mutation in our patients and the barrier abnormal-
ities. First, our observations underscore the presence of an
increased fragility of corneocytes in this disease. We
observed a plane of decreased tissue integrity within the
outermost granular layer (Fig 3). Decreased tissue integrity
within this plane, however, did not result in overt clinical signs
of increased skin/SC vulnerability; i.e., patients did not report
increased blister formation or susceptibility to injury. One
possible explanation is that compensatory overexpression
of other CE proteins (Koch et al, 2000; Steinert, 2000;
Jarnik et al, 2002), appears to normalize CE structure in the
outer SC of loricrin keratoderma, thereby reducing corneo-
cyte fragility. Nevertheless, we observed an impaired
mechanical resilience of the SC to torque and downward
pressure in a majority of the affected subjects tested (Table
S1), presumably due to a decrease in epidermal integrity.
The basis for abnormal fragility at the level of the outer
nucleated layers of the epidermis remains unknown. It is
possible that either mutant loricrin or the lack of normal
loricrin could disrupt the cytoskeleton. Alternatively, loricrin
deposition into the CE normally begins at the level of the
outer granular layer, and the failure of mutant loricrin to
translocate from the nucleus (Koch et al, 2000; Suga et al,
2000) could compromise the integrity of cell membrane in
the outer nucleated layers of the epidermis.
CE structures in the lower SC were both markedly
attenuated (about 30% of normal thickness, Fig 7) and
discontinuous (Fig 5) in patient versus control biopsy
samples. Yet, quantitatively the CE eventually attained
dimensions that were about 2/3 of normal thickness in the
outer SC. These observations probably explain why loricrin
keratoderma, in contrast to lamellar ichthyosis, scale, is
resistant to boiling in SDS and DTT, as is SC from normal
subjects. We would hypothesize further that the resiliance
of loricrin keratoderma scale to SDS/DTT treatment likely
reflects the assembly of other precursor proteins into the
CE, due to ongoing activity of transglutaminase-1, a
process that would be impaired in lamellar ichthyosis, even
in the presence of abundant Ca2þ (Fig 11). Low rates of
cross-linking into the CE are known to occur during the
transit of corneocytes from the inner to the outer layers even
in normal SC (Michel et al, 1988). Cross-linking may be
restricted in normals by the low levels of Ca2þ , in normal
SC (Menon et al, 1985), which are required for transgluta-
minase-1 catalytic activity (Rice and Green, 1979). In
contrast, the presence of substantial Ca2þ in lori-
crin keratoderma SC (Fig 10), and more specifically in
membrane domains, would favor on-going activity of
Figure 10
Calcium in stratum corneum (SC) correlates with
normalization of cornified envelope (CE) in loricrin
keratoderma. (A) Cytochemical localization of Ca2þ in
SC of loricrin keratoderma. Long arrow indicates putative,
outward movement of water and Ca2þ (OSC¼outer SC).
Note Ca2þ within corneocyte cytosol in lower SC (LSC),
but predominantly membrane/extracellular localization in
OSC. (B) Typical Ca2þ distribution in unaffected control
(co-epidermis, with little Ca2þ ion evident in SC). OsO4
post-fixation. Scale bar¼ 0.5 mm.
Figure 11
Theoretical basis for different scaffold abnormalities in loricrin
keratoderma versus lamellar ichthyosis (LI). (A) In loricrin kerato-
derma (1), mutant loricrin does not incorporate into cornified envelope
(CE), but other CE precursors incorporate progressively into CE due to
persistence of Ca2þ , as well as ongoing transglutaminase-1 activity.
In LI (2), such compensation cannot occur because of decreased
transglutaminase-1 activity.
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co-localized transglutaminase-1 within the CE. The basal
barrier abnormality in loricrin keratoderma, in turn, accounts
for elevated Ca2þ levels in the SC, because a similar
translocation of Ca2þ into the SC is seen in other chronic
dermatoses, characterized by a barrier abnormality (Menon
and Elias, 1991; Menon et al, 1994).
In this study, we report for the first time that the
ichthyosiform dermatosis in human loricrin keratoderma is
accompanied by a marked permeability barrier defect, and
that this functional defect can be attributed to abnormalities
in SC extracellular lamellar membrane structure. In loricrin
keratoderma subjects, lamellar bilayers were irregularly
configured, loosely organized, and/or fragmented, with
stacks of incompletely processed membranes interspersed
among normal-appearing, intact bilayers, features that all
were even more prominent in biopsies from acral (severely
involved) areas. Yet, permeability barrier repair kinetics
accelerate in loricrin keratoderma, a finding that is not
explicable by the abnormal CE scaffold and the abnormal
extracellular membrane structures. LB morphology and
secretion appear normal under baseline conditions, and
appear to accelerate following acute barrier disruption
in loricrin keratoderma. This hyperactive LB-secretory
response results in rapid replenishment of most of the
extracellular spaces (Menon et al, 1992a). As a result lipids
rapidly reaccumulate within the SC extracellular spaces
after acute disruption, with accelerated reformation of
(abnormal) membrane bilayers, and restoration of basal,
but still-abnormal barrier function in loricrin keratoderma.
The basis of this accelerated repair response remains
unknown since they did not correlate with qualitative
alterations in the epidermal Ca2þ gradient (Fig 10).
Together, these studies suggest that CE scaffold abnorm-
alities result in a markedly abnormal SC barrier under basal
conditions in human loricrin keratoderma, and that this
abnormality is due to distorted extracellular lamellae. Yet,
the LB secretory machinery is perennially upregulated,
presumably in compensation for the basal abnormality,
resulting in accelerated repair kinetics after acute insults.
Primary disorders of lipid metabolism, which alter the
extracellular (mortar) domains, inevitably are accompanied
by permeability barrier abnormalities (Williams, 1991).
Because the permeability barrier to water and electrolyte
movement resides in the extracellular, rather than in the
corneocyte (brick), compartment of the SC, it is not
immediately obvious why abnormalities in corneocyte
proteins; i.e., loricrin in loricrin keratoderma, keratins 1
and 10 in epidermolytic hyperkeratosis and transglutami-
nase-1 in lamellar ichthyosis produce permeability barrier
abnormalities (Elias et al, 2002; Schmuth et al, 2001b).
Moreover, perturbation/removal of the extracellular lipids by
solvent or detergent treatment alone, without affecting the
corneocytes, results in complete disruption of the perme-
ability barrier, as indicated by a massive increase in TEWL
(Scheuplein and Morgan, 1967). Yet, all human hereditary
disorders with corneocyte defects that have been studied to
date including loricrin keratoderma studied here, display
marked abnormalities in the quantities, morphology, and/or
organization of extracellular lipid bilayer system. Together,
these observations underscore the role of the corneocyte
and its constituent proteins as a scaffold that is critically
required for the normal organization of extracellular lipid
bilayers. Accordingly, loricrin, which normally provides up to
80% of the protein content to the CE, if mutated as in
human loricrin keratoderma, results in effete CE, ultimately
leading to abnormal organization of the lamellar bilayers and
a defect in SC extracellular permeability barrier.
Materials and Methods
Patients Sixteen patients (eight females, eight males, aged 11–79
y) with clinically typical loricrin keratoderma (Table S1) consented
to participate in these studies (protocol approved by UCSF
Committee on Human Research). All patients were members of a
large, previously described, and genotyped kindred (Maestrini et
al, 1996). 15 patients were evaluated by functional studies, full-
thickness skin biopsies were obtained from five of these subjects
(two females, three males, aged 25–69 y) and scale was obtained
from 11 patients (6 females, 5 males, aged 11–79 y) (Table S2). Skin
from five unaffected members of the same kindred (two females,
three males, aged 10–71 y), as well as six unrelated, age- and sex-
matched subjects without skin disease (four females, two males,
aged 21–47 y), comprised the two control groups. All affected
subjects displayed hyperkeratosis of palms, soles, and dorsum
of feet, extending proximally onto the wrists and ankles, with a
characteristic honeycomb appearance. Moreover, all affected
subjects also showed generalized fine scaling of mild-to-moderate
severity. In addition, some, but not all, affected individuals showed
variable, mild erythroderma, pruritus, hyperkeratosis of the knuckle
pads on the dorsal surface of the fingers, and nail dystrophy
(Table S1). Furthermore, several affected subjects either showed
a tendency for, or already had developed constricting bands of the
fourth and/or fifth digits of their hands and/or feet (pseudoainhum),
which had progressed in one subject to autoamputation of a digit.
Functional studies To assess epidermal permeability function we
measured TEWL over two separate sites; i.e., the wrist area
(honeycomb-like changes) and the volar forearm (fine-scaling
ichthyosis), in all loricrin keratoderma and control subjects using
a Tewameter (TM 210; Courage & Khazaka, Cologne, Germany).
Volunteers each underwent at least 15 min pre-assessment rest
period, and measurements were taken after further equilibration of
the probe on the skin surface. Environment-related variables at the
time of the study were: ambient air temperature 211C–241C; skin
surface temperature 30.81C–331C, ambient air humidity 58%–
66%. TEWL was measured both under basal conditions, as well as
following acute barrier disruption by repeated cellophane tape
stripping (to TEWL42 mg per cm3 per h). Barrier recovery kinetics
then were assessed by measuring TEWL at 3 and/or 6 h after acute
disruption. For calculation of the percent change in TEWL, the
following formula was used: {(TEWL stripped area at indicated
time/TEWL control area at indicated time)/(TEWL stripped area
before stripping/TEWL control area before stripping)1}  100%.
Surface pH was measured using a Skin-pH-Meter (PH900;
Courage & Khazaka), equipped with a flat glass electrode
(Mettler-Toledo, Giessen, Germany). SC hydration was assessed
as changes in electrical capacitance (absolute units) with a
Corneometer (CM 825; Courage & Khazaka). Finally, in ten loricrin
keratoderma subjects (6 females, 4 males, aged 11–79 y), SC
fragility was assessed clinically by application of controlled friction
(torque) with slight pressure, by rotating a new pencil eraser on the
skin surface as described previously (Williams and Elias, 1981a)
(‘‘pseudo-Nikolskij’’ sign according to Grando et al, 2003).
SC cohesion was assessed as protein removed per D-Squame
strip. Before stripping the SC, the skin surface was cleaned with a
single ethanol wipe. D-Squame tapes then were placed sequen-
tially to the test areas for about 3 s each, removed with the forceps,
and stored in glass scintillation vials at 51C. The amount of protein
removed per D-Squame was measured, by a modification of the
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method of Dreher et al (1998). The protein content per stripping
was determined with the Bio-Rad Protein Assay Kit (Biorad,
Hercules, CA). Lyophilized, bovine g globulin was used as the
standard in all assays. Each tape was incubated with 1 mL of 1 M
NaOH for 1 h at 371C in a shaker and neutralized thereafter with
1 mL of 1 M HCl in the scintillation vials. Subsequently 0.2 mL of
this solution was incubated in 0.6 mL distilled water plus 0.2 mL of
the Bio-Rad protein dye for 5 min in borosilicate tubes. After
incubations, the reagents were transferred to polysterene cuvettes,
and absorption was measured with a Genesys 5 spectrophot-
ometer (Spectronic, Rochester, New York) at 595 nm. An empty D-
Squame tape, as well as distilled water incubated with the Bio-Rad
dye, served as negative controls. The amount of calculated protein
was then normalized to skin surface area (mg per cm2).
Biopsies and assessment of CE fragility Biopsies from loricrin
keratoderma and control skin sites were taken immediately before,
3 and/or 6 h after acute barrier disruption (Table S2). To further
assess SC fragility, tissue blocks were pre-sectioned using a
scalpel blade, examined for clefts under a dissecting microscope,
and photomicrographs were taken using a Nikon Microphot-FX
camera (Nikon Inc., Melville, New York) in the dark-field mode. To
assess whether increased corneocyte fragility can be attributed
to a defective CE, we isolated CE from loricrin keratoderma and
control scale samples (sunburn), as described recently (Elias et al,
2002). Isolated scale was placed in 2% SDS and 20 mM
dithiothreitol (DTT) in 50 mM Tris buffer, and boiled for 5 min. After
centrifuging (1000  g  10 min), CE suspensions were assessed
by light microscopy in the Nomarsky mode (Jeon et al, 1998).
Histology and immunohistochemistry Skin sections (6 mm) were
fixed in 4% formaldehyde, embedded in paraffin, stained with
hematoxylin & eosin and photographed with an Axiovision 2
Imaging Zeiss light microscope (Jena, Germany), using Axiovision
software (Munich, Germany). For immunohistochemistry, paraffin
sections (6 mm) were incubated for 30 min in blocking buffer (1%
bovine serum albumin, 0.1% cold water fish gelatin in phosphate-
buffered saline, PBS) and then incubated for 2 h at room
temperature with a primary rabbit antibody against the C-terminus
(HQTQQKQAPTWPCK) of loricrin (BabCo, Richmond, California),
diluted (1:500) in blocking buffer. Tissue sections were washed with
PBS and incubated for 1 h at room temperature with a goat anti-
rabbit antibody (Vector Labs, Burlingame, California), and diluted in
blocking buffer. Tissue sections then were washed with PBS and
coverslipped before visualization under a confocal microscope
(Leica TCS SP, Heidelberg, Germany) at an excitation wavelength
of 488 nm and an emission wavelength of 518 nm.
Ultrastructural studies
Approach To assess the morphological basis for the barrier
abnormality in patients with loricrin mutations, we employed an
algorithmic sequence similar to that recently applied to Harlequin
ichthyosis (Elias et al, 2000b), epidermolytic hyperkeratosis
(Schmuth et al, 2001b), and lamellar ichthyosis (Elias et al, 2002).
Since permeability barrier function was abnormal, we initially
assessed the ultrastructural morphology of the CE/CLE corneocyte
scaffold. Then, using the water-soluble, low molecular weight
tracer, colloidal lanthanum (Williams and Elias, 1981a), we
determined whether the permeability abnormality is due to leaky
corneocytes, resulting in increased transcellular water movement
(fragility), or to enhanced intercellular permeability (scaffold)
(normal SC excludes lanthanum movement). When permeability
occurs predominantly via an intercellular route (as it did here), we
then assessed extracellular lamellar bilayer quantities and their
supramolecular organization. Finally, LB morphology and the
extent of LB secretion were assessed to determine whether the
mutant protein interferes with secretion of LB contents.
Assessment of permeability pathway by lanthanum perfusion The
perfusion pathway was assessed by immersion of loricrin
keratoderma biopsies and/or scale in 4% lanthanum nitrate in
0.05 M Tris buffer, pH 7.4, containing 2% glutaraldehyde and 1%
paraformaldehyde for 1 h at room temperature (Elias et al, 2002;
Schmuth et al, 2001b). After lanthanum perfusion, the samples
were washed and processed for electron microscopy, as described
below.
Assessment of corniﬁed envelope-associated structures Using a
combination of osmium (OsO4) and ruthenium tetroxide (RuO4)
post-fixation with pyridine pre-treatment, it is possible to assess
the integrity of the intercellular lamellar bilayer system in relation
to the CE/CLE scaffold (Elias, 1996; Elias et al, 2000b). Skin
samples, minced to o0.5 mm3 each, were pre-fixed in half-
strength Karnovsky’s fixative, followed by post-fixation in reduced
1% OsO4 or 0.2% RuO4 (Madison et al, 1987), as modified by Hou
et al (1991). Whereas RuO4 post-fixation allows visualization of
extracellular lamellar bilayer substructure and organization, for
visualization of the CE/CLE membrane complex, parallel samples
then were immersed for 2 h in absolute pyridine, as described
recently (Elias et al, 2000b, 2002), and processed further as
described below. All OsO4 and RuO4 post-fixed samples were
dehydrated in a graded ethanol/propylene oxide series, and
embedded in an Epon–epoxy mixture. Ultrathin sections assessed
either unstained, or after further, lead citrate contrasting in a Zeiss
10A electron microscope operated at 60 kV (Zeiss, Ober Kochen,
Germany).
Quantitation of CE dimensions Both biopsy and scale samples
were soaked in absolute pyridine for 2 h, rinsed three times in
0.1 M cacodylate buffer, and then fixed in 1/2 strength Karnovsky’s,
followed by reduced osmium post-fixation and Epon embedding
(as above). Samples were photographed at  31.5 and further
enlarged  2 on a photocopier. Envelope thickness was measured
randomly at every 0.5 cm point along CE in lower versus outer SC.
At least 30 different areas were randomly photographed from each
sample by an unbiased observer, and the mean  SEM was
calculated for patient versus control samples. A total of four loricrin
keratoderma biopsies, three loricrin keratoderma scale samples,
one control biopsy (unaffected family member), and three control
scale samples from unrelated, sunburn patients were assessed.
Assessment of LB secretion To assess the LB secretory system,
the following criteria were assessed: (a) amount of secreted
material at the SG–SC interface (Menon et al, 1992a); (b) presence
of ‘‘entombed’’ LB within the corneocyte cytosol (Schmuth et al,
2001); and (c) extent of extracellular delivery versus corneocyte
retention of a lipid hydrolase (acid lipase), which is concentrated in
LB, and normally secreted and segregated in toto within the SC
interstices (Menon et al, 1986, 1992b; Elias et al, 2002). This
method provides a useful indicator of retention of LB contents
in disorders of cornification (Menon et al, 1992b; Schmuth et al,
2001b; Elias et al, 2002). Aldehyde-pre-fixed samples were
microwave-incubated with 0.2% Tween 85-containing substrate
(  lipase inhibitor, tetrahydrolipstatin, 200 mM), a lead-capture,
cytochemical method that depicts the localization of acidic and
neutral lipases (Rassner et al, 1997). Samples for enzyme
cytochemistry then were post-fixed in OsO4 and processed, as
above.
Ion capture cytochemistry The epidermal calcium gradient inver-
sely regulates LB secretion in normal epidermis; i.e., accelerated
secretion occurs in response to lowered extracellular calcium
(Menon et al, 1985; Lee et al, 1992). An acute reduction in
epidermal calcium explains the normalized kinetics of barrier
recovery in epidermolytic hyperkeratosis after further acute
abrogations of the barrier (Schmuth et al, 2001b). For ultrastructur-
al visualization of the epidermal calcium gradient, parallel biopsy
samples from affected and unaffected controls were obtained both
before and after acute barrier disruption (see above), fixed in 2%
paraformaldehyde, 2% glutaraldehyde, 0.09 M potassium oxalate,
containing 0.04 M sucrose overnight at 41C, and then post-fixed in
1% OsO4, containing 2% potassium pyroantimonate, pH 7.4, for
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2 h at 41C in the dark (Menon et al, 1985). Tissue samples then
were washed in alkalinized water (pH 10), and dehydrated in
graded ethanol solutions, prior to embedding, as above.
Analysis of covalently bound ceramides Total lipid extracts
were obtained from loricrin keratoderma and control scale, and
covalently bound lipids were isolated by saponification of the
exhaustively extracted samples, as described previously (Holleran
et al, 1991). Bound and unbound lipid extracts were quantitated
after fractionation in a sphingolipid solvent system (Wertz et al,
1989; Elias et al, 2002). Data were expressed as lipid fraction per
mg protein, assessed on the post-saponification scale samples.
Statistics Statistical comparisons were performed using either
paired or unpaired Student’s t test, as appropriate. When three or
more groups were compared, an ANOVA analysis was utilized.
Statistical analyses were performed with Prism3 software (Graph-
Pad, San Diego, California). Data are expressed as mean  SEM.
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